XTX Topco’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-36,520
| Closed | -$593K | – | 2019 |
|
|
2024
Q2 | $593K | Buy |
+36,520
| New | +$593K | 0.05% | 577 |
|
|
2024
Q1 | – | Sell |
-12,961
| Closed | -$406K | – | 1776 |
|
|
2023
Q4 | $406K | Sell |
12,961
-22,962
| -64% | -$719K | 0.09% | 389 |
|
|
2023
Q3 | $749K | Buy |
+35,923
| New | +$749K | 0.13% | 194 |
|
|
2023
Q2 | – | Sell |
-31,261
| Closed | -$588K | – | 1359 |
|
|
2023
Q1 | $588K | Buy |
31,261
+6,686
| +27% | +$126K | 0.12% | 208 |
|
|
2022
Q4 | $391K | Sell |
24,575
-14,096
| -36% | -$224K | 0.08% | 419 |
|
|
2022
Q3 | $633K | Buy |
+38,671
| New | +$633K | 0.16% | 153 |
|
|
2021
Q3 | – | Sell |
-11,903
| Closed | -$290K | – | 655 |
|
|
2021
Q2 | $290K | Buy |
+11,903
| New | +$290K | 0.1% | 377 |
|